Principal Financial Group Inc reports 11.94% increase in ownership of 1CYTK / Cytokinetics, Incorporated

Cytokinetics, Incorporated

IT ˙ BIT ˙ US23282W6057

62,32 € 0,00 (0,00%)

2026-06-05
DEL PRIS

Security	IT:1CYTK / Cytokinetics, Incorporated
Institution	Principal Financial Group Inc
Latest Disclosed Ownership	1,093,485 shares
Latest Disclosed Value	$ 72,071,596

On May 4, 2026 - Principal Financial Group Inc filed a 13F-HR form disclosing ownership of 1,093,485 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $59,048,190 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 976,892 shares of Cytokinetics, Incorporated. This represents a change in shares of 11.94% during the quarter. The current value of the position is $68,145,985 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-04	2026-03-31	13F	CYTOKINETICS	COM NEW	23282W605	1,093,485	116,593	11.94	72,072	16.11	0.0196
2026-02-02	2025-12-31	13F	CYTOKINETICS	COM NEW	23282W605	976,892	-197,556	-16.82	62,072	-3.84	0.0317
2025-11-04	2025-09-30	13F	CYTOKINETICS	COM NEW	23282W605	1,174,448	-10,357	-0.87	64,548	64.89	0.0326
2025-08-08	2025-06-30	13F	CYTOKINETICS	COM NEW	23282W605	1,184,805	554,894	88.09	39,146	54.63	0.0207
2025-04-28	2025-03-31	13F	CYTOKINETICS	COM NEW	23282W605	629,911	358,778	132.33	25,316	98.49	0.0142
2025-01-31	2024-12-31	13F	CYTOKINETICS	COM NEW	23282W605	271,133	-1,949	-0.71	12,754	-11.54	0.0070
2024-10-31	2024-09-30	13F	CYTOKINETICS	COM NEW	23282W605	273,082	-120,497	-30.62	14,419	-32.39	0.0079
2024-07-29	2024-06-30	13F	CYTOKINETICS	COM NEW	23282W605	393,579	-37,977	-8.80	21,324	-29.52	0.0127
2024-04-29	2024-03-31	13F	CYTOKINETICS	COM NEW	23282W605	431,556	-89,616	-17.20	30,256	-30.47	0.0178
2024-02-07	2023-12-31	13F	CYTOKINETICS	COM NEW	23282W605	521,172	-4,111	-0.78	43,513	181.19	0.0277
2023-11-02	2023-09-30	13F	CYTOKINETICS	COM NEW	23282W605	525,283	-30,432	-5.48	15,475	-14.64	0.0111
2023-08-07	2023-06-30	13F	CYTOKINETICS	COM NEW	23282W605	555,715	-27,189	-4.66	18,127	-11.63	0.0124
2023-05-09	2023-03-31	13F	CYTOKINETICS	COM NEW	23282W605	582,904	-82,480	-12.40	20,512	-32.72	0.0147
2023-02-09	2022-12-31	13F	CYTOKINETICS	COM NEW	23282W605	665,384	52,937	8.64	30,488	2.74	0.0230
2022-11-09	2022-09-30	13F	CYTOKINETICS	COM NEW	23282W605	612,447	-60,821	-9.03	29,673	12.17	0.0236
2022-08-10	2022-06-30	13F	CYTOKINETICS	COM NEW	23282W605	673,268	15,120	2.30	26,453	9.19	0.0196
2022-05-09	2022-03-31	13F	CYTOKINETICS	COM NEW	23282W605	658,148	-18,968	-2.80	24,226	-21.50	0.0096
2022-05-09	2022-03-31	13F	CYTOKINETICS	COM NEW	23282W605	644,347			23,718
2022-02-09	2021-12-31	13F	CYTOKINETICS	COM NEW	23282W605	677,116	77,885	13.00	30,863	44.11	0.0184
2021-11-09	2021-09-30	13F	CYTOKINETICS	COM NEW	23282W605	599,231	76,150	14.56	21,416	106.88	0.0140
2021-08-10	2021-06-30	13F	CYTOKINETICS	COM NEW	23282W605	523,081	5,362	1.04	10,352	-14.03	0.0067
2021-05-10	2021-03-31	13F	CYTOKINETICS	COM NEW	23282W605	517,719	704	0.14	12,042	12.09	0.0085
2021-02-23	2020-12-31	13F/A-1	CYTOKINETICS	COM NEW	23282W605	517,015	-9,345	-1.78	10,743	-5.72	0.0080
2021-02-08	2020-12-31	13F	CYTOKINETICS	COM NEW	23282W605	517,015	-9,345		10,743		4,226.4618
2020-11-06	2020-09-30	13F	CYTOKINETICS	COM NEW	23282W605	526,360	60,673	13.03	11,395	3.81	0.0096
2020-08-05	2020-06-30	13F	CYTOKINETICS	COM NEW	23282W605	465,687	8,348	1.83	10,977	103.58	0.0097
2020-05-12	2020-03-31	13F	CYTOKINETICS	COM NEW	23282W605	457,339	-18,007	-3.79	5,392	6.92	0.0060
2020-02-05	2019-12-31	13F	CYTOKINETICS	COM NEW	23282W605	475,346	12,529	2.71	5,043	-4.25	0.0042
2019-11-13	2019-09-30	13F	CYTOKINETICS	COM NEW	23282W605	462,817	-114	-0.02	5,267	1.13	0.0046
2019-08-12	2019-06-30	13F	CYTOKINETICS	COM NEW	23282W605	462,931	23,282	5.30	5,208	46.42	0.0047
2019-05-10	2019-03-31	13F	CYTOKINETICS	COM NEW	23282W605	439,649	-4,529	-1.02	3,557	26.72	0.0033
2019-02-14	2018-12-31	13F	CYTOKINETICS	COM NEW	23282W605	444,178	-5,089	-1.13	2,807	-36.56	0.0030
2018-11-14	2018-09-30	13F	CYTOKINETICS	COM NEW	23282W605	449,267	44,452	10.98	4,425	31.70	0.0039
2018-08-13	2018-06-30	13F	CYTOKINETICS	COM NEW	23282W605	404,815	7,212	1.81	3,360	17.36	0.0031
2018-05-14	2018-03-31	13F	CYTOKINETICS	COM NEW	23282W605	397,603	9,786	2.52	2,863	-9.43	0.0028
2018-02-12	2017-12-31	13F	CYTOKINETICS	COM NEW	23282W605	387,817	-68,320	-14.98	3,161	-52.21	0.0029
2017-11-02	2017-09-30	13F	CYTOKINETICS	COM NEW	23282W605	456,137	28,708	6.72	6,614	27.88	0.0064
2017-08-08	2017-06-30	13F	CYTOKINETICS	COM NEW	23282W605	427,429	427,429		5,172		0.0052
2015-02-12	2014-12-31	13F	CYTOKINETICS	COM NEW	23282W605	0	-11,368	-100.00	0	-100.00
2014-11-13	2014-09-30	13F	CYTOKINETICS	COM NEW	23282W605	11,368	0	0.00	40	-25.93	0.0001
2014-08-12	2014-06-30	13F	CYTOKINETICS	COM NEW	23282W605	11,368	-317,308	-96.54	54	-98.27	0.0001
2014-05-13	2014-03-31	13F	CYTOKINETICS	COM NEW	23282W605	328,676	10,789	3.39	3,122	51.11	0.0056
2014-02-12	2013-12-31	13F	CYTOKINETICS	COM NEW	23282W605	317,887	4,700	1.50	2,066	-13.08	0.0039
2013-11-05	2013-09-30	13F	CYTOKINETICS	COM NEW	23282W605	313,187	313,187		2,377		0.0049

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.